Stock Based Compensation (Tables)

6 Months Ended

Mar. 31, 2019

Schedule Of Stock Compensation Expense [Table Text Block]

Stock compensation expense for the three and six months ended March 31, 2019 and 2018 is as follows:

	Three Months Ended		Three Months Ended
	March 31, 2019		March 31, 2018
Stock Grants	$	91,000	$	91,000
Restricted Stock Grants		9,000		13,000
Option Grants		-		5,000
Employee Stock Purchase Plan		1,000		-
Subsidiary Option Grants		11,000		28,000
Total	$	112,000	$	137,000
	Six Months Ended		Six Months Ended
	March 31, 2019		March 31, 2018
Stock Grants	$	142,000	$	130,000
Restricted Stock Grants		24,000		26,000
Option Grants		-		17,000
Employee Stock Purchase Plan		2,000		1,000
Subsidiary Option Grants		22,000		56,000
Total	$	190,000	$	230,000

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

A summary of restricted stock activity for the six months ended March 31, 2019 is presented below:

Restricted Stock Activity for the Six Months ended March 31, 2019	Shares			Weighted-Average Grant-Date Fair Value
Nonvested at September 30, 2018		60,000		$	1.61
Granted		-			-
Vested		(30,000	)		1.73
Cancelled		-			-
Nonvested and expected to vest at March 31, 2019		30,000		$	1.48

Stock Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

During the six months ended March 31, 2019, no Dynasil stock options were granted. A summary of stock option activity for the six months ended March 31, 2019 is presented below:

	Options Outstanding			Weighted Average Exercise Price per Share		Weighted Average Remain Contractual Term (in Years)
Balance at September 30, 2018		160,537		$	2.01		0.93
Outstanding and exercisable at September 30, 2018		160,537		$	2.01		0.93
Granted		-			-
Exercised		-			-
Cancelled		(64,935	)		2.33
Balance at March 31, 2019		95,602		$	1.80		0.84
Outstanding and exercisable at March 31, 2019		95,602		$	1.80		0.84

Subsidiary Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

During the six months ended March 31, 2019, no Xcede stock options were granted. A summary of Xcede stock option activity for the six months ended March 31, 2019 is presented below:

	Options Outstanding		Weighted Average Exercise Price per Share		Weighted Average Remain Contractual Term (in Years)
Balance at September 30, 2018		1,300,956	$	1.00		7.31
Outstanding and exercisable at September 30, 2018		1,229,685		1.00		7.11
Granted		-		-
Exercised		-		-
Cancelled		-		-
Balance at March 31, 2019		1,300,956		1.00		6.60
Outstanding and exercisable at March 31, 2019		1,266,581	$	1.00		6.60